Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Babu G. Sundar is active.

Publication


Featured researches published by Babu G. Sundar.


Bioorganic & Medicinal Chemistry Letters | 2011

Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity

Robert L. Hudkins; Lisa D. Aimone; Thomas R. Bailey; Robert J. Bendesky; Reddeppa reddy Dandu; Derek Dunn; John A. Gruner; Kurt A. Josef; Yin-Guo Lin; Jacquelyn A. Lyons; Val R. Marcy; Joanne R. Mathiasen; Babu G. Sundar; Ming Tao; Allison L. Zulli; Rita Raddatz; Edward R. Bacon

H(3)R structure-activity relationships on a novel class of pyridazin-3-one H(3)R antagonists/inverse agonists are disclosed. Modifications of the pyridazinone core, central phenyl ring and linker led to the identification of molecules with excellent target potency, selectivity and pharmacokinetic properties. Compounds 13 and 21 displayed potent functional H(3)R antagonism in vivo in the rat dipsogenia model and demonstrated robust wake activity in the rat EEG/EMG model.


Bioorganic & Medicinal Chemistry Letters | 2011

Amine-constrained pyridazinone histamine H3 receptor antagonists

Babu G. Sundar; Thomas R. Bailey; Edward R. Bacon; Lisa D. Aimone; Zeqi Huang; Jacquelyn A. Lyons; Rita Raddatz; Robert L. Hudkins

Pyridazinone 1 was recently reported as a potent H(3)R antagonist with good drug-like properties and in vivo activity. A series of constrained amine analogs of 1 was synthesized to identify compounds with improved pharmacokinetic profiles. From these efforts, a new class of (S)-2-pyrrolidin-1-ylmethyl-1-pyrrolidinyl amides was identified.


Bioorganic & Medicinal Chemistry Letters | 2012

Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity

Babu G. Sundar; Thomas R. Bailey; Derek Dunn; Greg A. Hostetler; Sankar Chatterjee; Edward R. Bacon; Christoph Yue; Dominique Schweizer; Lisa D. Aimone; John A. Gruner; Jacquelyn A. Lyons; Rita Raddatz; Brigitte Lesur

Structure-activity relationship on a novel ketone class of H(3)R antagonists/inverse agonists is disclosed. Compound 4 showed excellent target potency, selectivity and brain penetration. Evaluation of antagonist 4 in the rat EEG/EMG model demonstrated robust wake activity thereby establishing preclinical proof of concept.


Bioorganic & Medicinal Chemistry Letters | 2012

Novel brain penetrant benzofuropiperidine 5-HT6 receptor antagonists

Babu G. Sundar; Thomas R. Bailey; Derek Dunn; Edward R. Bacon; Joseph M. Salvino; George C. Morton; Lisa D. Aimone; Huang Zeqi; Joanne R. Mathiasen; Amy DiCamillo; Mark J. Huffman; Beth Ann McKenna; Karla Kopec; Lily D. Lu; Rebecca Brown; Jie Qian; Thelma S. Angeles; Thomas J. Connors; Chrysanthe Spais; Beverly P. Holskin; Deborah Galinis; Emir Duzic; Hervé Schaffhauser; Gerard C. Rosse

7-Arylsulfonyl substituted benzofuropiperidine was discovered as a novel scaffold for 5HT(6) receptor antagonists. Optimization by substitution at C-1 position led to identification of selective, orally bioavailable, brain penetrant antagonists with reduced hERG liability. An advanced analog tested in rat social recognition model showed significant activity suggesting potential utility in the enhancement of short-term memory.


Synthetic Communications | 2011

1-Phenyl-2-pyrrolidinyl-cyclopentylamine via Thermal Rearrangement

Babu G. Sundar; Kurt A. Josef; Robert J. McHugh; Curtis R. Haltiwanger

Abstract Thermal rearrangement of aminoimine, 1, followed by hydrogenation produced 1-phenyl-2-pyrrolidinyl cyclopentylamine 3. The structure and stereochemistry of this novel amine 4 was identified by x-ray crystallography of the 2-chloro-6-iodo-nicotinamide derivative as a hydrogen maleate salt.


Archive | 2009

Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands

Nadine C. Becknell; Reddeppa reddy Dandu; Derek Dunn; Robert L. Hudkins; Kurt A. Josef; Babu G. Sundar; Allison L. Zulli


Archive | 2011

PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS

Henry J. Breslin; Sankar Chatterjee; James L. Diebold; Bruce D. Dorsey; Derek Dunn; Diane E. Gingrich; Greg A. Hostetler; Robert L. Hudkins; Rachael Hunter; Kurt A. Josef; Joseph G. Lisko; Eugen F. Mesaros; Karen L. Milkiewicz; Gregory R. Ott; Babu G. Sundar; Jay Theroff; Tho V. Thieu; Rabindranath Tripathy; Theodore L. Underiner; Linda Weinberg; Gregory J. Wells; Craig A. Zificsak


Archive | 2011

Substituted pyridazine derivatives

Robert L. Hudkins; Lars J. S. Knutsen; Catherine P. Prouty; Babu G. Sundar; Kevin J. Wells-Knecht


Archive | 2011

Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands

Edward R. Bacon; Thomas R. Bailey; Sankar Chatterjee; Derek Dunn; Greg A. Hostetler; Robert L. Hudkins; Brigitte Lesur; Babu G. Sundar; Allison L. Zulli; Christophe Yue


Archive | 2010

Tricyclic derivatives and their pharmaceutical use and compositions

Edward R. Bacon; Thomas R. Bailey; Derek Dunn; Greg A. Hostetler; Robert J. McHugh; George C. Morton; Gerard C. Rosse; Joseph M. Salvino; Babu G. Sundar; Rabindranath Tripathy

Collaboration


Dive into the Babu G. Sundar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kurt A. Josef

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar

Sankar Chatterjee

Case Western Reserve University

View shared research outputs
Researchain Logo
Decentralizing Knowledge